| Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent (NCT01081821) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-02-01 |
| Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM) (NCT01053728) | Sanofi | 2010-02-01 |
| Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069) (NCT01071291) | Merck Sharp & Dohme LLC | 2010-02-01 |
| Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease (NCT01716637) | Life Extension Foundation Inc. | 2010-02-01 |
| Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers (NCT01074710) | Otsuka Pharmaceutical Co., Ltd. | 2010-02-01 |
| Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir) (NCT01227590) | University of California, San Francisco | 2010-02-01 |
| A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers (NCT01088594) | Solvay Pharmaceuticals | 2010-02-01 |
| Study to Investigate ADME of 14C Labeled SLV334 After an i.v. Infusion (NCT01044524) | Solvay Pharmaceuticals | 2010-02-01 |
| Reproducibility of Malaria Challenge in Healthy Volunteers (NCT01058226) | Seattle Children's Hospital | 2010-02-01 |
| Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation (NCT01086735) | Assistance Publique - Hôpitaux de Paris | 2010-02-01 |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy (NCT01164215) | UNC Lineberger Comprehensive Cancer Center | 2010-02-01 |
| Ketamine Challenge Study With JNJ-40411813 (NCT01101659) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-02-01 |
| Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770 (NCT01060566) | Vertex Pharmaceuticals Incorporated | 2010-02-01 |
| Wrinkle Injection With Autologous Platelet Rich Plasma Study (NCT01078493) | Novena Medical Center | 2010-02-01 |
| Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis (NCT01038674) | Novo Nordisk A/S | 2010-02-01 |
| Brief Interventions in General Hospital (BIG) (NCT00982306) | Partnerships in Care | 2010-02-01 |
| A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer (NCT00927875) | Bristol-Myers Squibb | 2010-02-01 |
| Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors (NCT01076530) | National Cancer Institute (NCI) | 2010-02-01 |
| Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC (NCT01063478) | University of Chicago | 2010-02-01 |
| Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse (NCT01311778) | Hurd,Yasmin, Ph.D. | 2010-02-01 |
| A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects (NCT01104532) | Astellas Pharma Inc | 2010-02-01 |
| Drug Discrimination in Methadone-Maintained Humans Study 3 (NCT01068847) | University of Arkansas | 2010-02-01 |
| Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure (NCT01152411) | International Stemcell Services Limited | 2010-02-01 |
| S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer (NCT01175447) | Zhejiang Cancer Hospital | 2010-02-01 |
| The Effects of Hydrocortisone in Endotoxemia in Normal Volunteers (NCT01064986) | Rutgers, The State University of New Jersey | 2010-02-01 |
| Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects (NCT01068730) | AstraZeneca | 2010-02-01 |
| DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer (NCT00972023) | Barbara Ann Karmanos Cancer Institute | 2010-02-01 |
| Dexamethasone in the Treatment of Bronchiolitis in Patients With Either Eczema and or Family History of Asthma (NCT01065272) | Hamad Medical Corporation | 2010-02-01 |
| Study of EZN-2208 Pediatric Patients With Solid Tumors (NCT01295697) | Enzon Pharmaceuticals, Inc. | 2010-02-01 |
| Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema (NCT01042678) | Allergan | 2010-02-01 |
| Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered (NCT01068743) | AstraZeneca | 2010-02-01 |
| Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies (NCT01096355) | National Cancer Institute (NCI) | 2010-02-01 |
| Chemoreflex Gain on Exercise (NCT01050179) | Imperial College London | 2010-02-01 |
| A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors (NCT01075464) | Genentech, Inc. | 2010-02-01 |
| Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta (NCT01061099) | Nationwide Children's Hospital | 2010-02-01 |
| RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer (NCT01058655) | Dana-Farber Cancer Institute | 2010-02-01 |
| Trichuris Suis Ova in Peanut and Tree Nut Allergy (NCT01070498) | Beth Israel Deaconess Medical Center | 2010-02-01 |
| Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults (NCT01260727) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-01 |
| A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers (NCT01543269) | Zydus Lifesciences Limited | 2010-02-01 |
| A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) (NCT01100931) | National Cancer Institute (NCI) | 2010-02-01 |
| Safety and Tolerability of LIM-0705 in Healthy Male Subjects (NCT01060475) | Limerick BioPharma | 2010-02-01 |
| Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder (NCT01903200) | Astellas Pharma Inc | 2010-02-01 |
| We Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans (NCT01227473) | University of North Carolina, Chapel Hill | 2010-02-01 |
| A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 Days (NCT01064388) | AstraZeneca | 2010-02-01 |
| Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer (NCT00934076) | University of Alabama at Birmingham | 2010-02-01 |
| Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction (NCT01083537) | University Health Network, Toronto | 2010-02-01 |
| Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD) (NCT01504945) | Beth Israel Deaconess Medical Center | 2010-02-01 |
| Gene Therapy for Painful Diabetic Neuropathy (NCT01002235) | Helixmith Co., Ltd. | 2010-02-01 |
| A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 Tablet (NCT01125670) | Astellas Pharma Inc | 2010-02-01 |
| Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella (NCT01069471) | GlycoVaxyn AG | 2010-02-01 |
| A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain (NCT00947466) | Mundipharma Research Limited | 2010-02-01 |
| Evaluating an Ebola and a Marburg Vaccine in Uganda (NCT00997607) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-01 |
| L-NMMA Dose-response Study in Healthy Subjects (NCT01070940) | Regional Hospital Holstebro | 2010-02-01 |
| A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting Conditions (NCT01092299) | AstraZeneca | 2010-02-01 |
| A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens (NCT01009190) | pharmaand GmbH | 2010-02-01 |
| Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres (NCT02870010) | Centre Hospitalier Universitaire Dijon | 2010-02-01 |
| Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK) (NCT00935363) | University of California, San Francisco | 2010-02-01 |
| A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01068184) | AstraZeneca | 2010-02-01 |
| A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood Glucose (NCT01072578) | AstraZeneca | 2010-02-01 |
| AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies (NCT01065662) | Susana M. Campos, MD | 2010-02-01 |
| Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting Condition (NCT01671709) | Dr. Reddy's Laboratories Limited | 2010-02-01 |
| Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin (NCT01081353) | Bayer | 2010-02-01 |
| Pharmacokinetics in Morbid Obesity After Bariatric Surgery (NCT01086722) | Fundacion IMIM | 2010-02-01 |
| Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics (NCT02169414) | Bial - Portela C S.A. | 2010-02-01 |
| Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus (NCT01082120) | AstraZeneca | 2010-02-01 |
| Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition (NCT02296762) | Dr. Reddy's Laboratories Limited | 2010-02-01 |
| Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma (NCT01686386) | Gruppo Italiano Studio Linfomi | 2010-02-01 |
| Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers (NCT01103830) | sigma-tau i.f.r. S.p.A. | 2010-02-01 |
| Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear Cells (NCT01414634) | Universitätsklinikum Hamburg-Eppendorf | 2010-02-01 |
| A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis (NCT01085760) | Mayo Clinic | 2010-02-01 |
| Safety and Feasibility of Minocycline in the Treatment of Traumatic Brain Injury (TBI) (NCT01058395) | Wayne State University | 2010-02-01 |
| Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer (NCT00983424) | Northwestern University | 2010-02-01 |
| A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus (NCT01044537) | Pfizer | 2010-02-01 |
| Dose Escalation of HSP990 in Japan/Korea (NCT01064089) | Novartis Pharmaceuticals | 2010-02-01 |
| Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer (NCT01423903) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-02-01 |
| A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol (NCT01099839) | Astellas Pharma Inc | 2010-02-01 |
| Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide (NCT01059071) | Giselle Sholler | 2010-02-01 |
| Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers (NCT01389466) | Green Cross Corporation | 2010-02-01 |
| A Phase 1 Study To Estimate The Relative Bioavailability And Food Effect Of PF-04620110 In Healthy Adult Subjects (NCT01064492) | Pfizer | 2010-02-01 |
| A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male Volunteers (NCT01068223) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-02-01 |
| A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies (NCT01290380) | Novartis Pharmaceuticals | 2010-02-01 |
| A Phase 1 Study in Participants With Advanced Cancer (NCT01115790) | Eli Lilly and Company | 2010-02-01 |
| Study to Evaluate the Safety of a Single Escalating Dose of ACRX-100 in Adults With Ischemic Heart Failure (NCT01082094) | Juventas Therapeutics, Inc. | 2010-02-01 |
| Development and Evaluation of a Nursing Virtual Intervention Tailored for Pain After Cardiac Surgery (NCT01084018) | Centre hospitalier de l'Université de Montréal (CHUM) | 2010-02-01 |
| Western Equine Encephalitis Vaccine, Inactivated (NCT01159561) | U.S. Army Medical Research and Development Command | 2010-02-01 |
| Phase 1 Dosing Study of BAX 513 in Healthy Volunteers (NCT01063101) | Baxalta now part of Shire | 2010-01-29 |
| Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia. (NCT01041508) | Therapeutic Advances in Childhood Leukemia Consortium | 2010-01-29 |
| Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma (NCT01051557) | National Cancer Institute (NCI) | 2010-01-27 |
| ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer (NCT01075048) | Daiichi Sankyo | 2010-01-26 |
| A Confirmation Study of Eribulin in Combination With Capecitabine (NCT01323530) | Eisai Limited | 2010-01-26 |
| A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas (NCT01051635) | National Cancer Institute (NCI) | 2010-01-25 |
| Renal Impairment Study With ASP1941 (NCT01302028) | Astellas Pharma Inc | 2010-01-22 |
| A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid Arthritis (NCT01754805) | Astellas Pharma Inc | 2010-01-22 |
| Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis (NCT01071616) | National Institute on Drug Abuse (NIDA) | 2010-01-22 |
| Rituximab for Autoimmune Retinopathy (NCT01086631) | National Eye Institute (NEI) | 2010-01-22 |
| Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma (NCT01016730) | National Cancer Institute (NCI) | 2010-01-22 |
| Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633 (NCT01086462) | GlaxoSmithKline | 2010-01-21 |
| MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy (NCT01068587) | NCIC Clinical Trials Group | 2010-01-21 |
| Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal Spray (NCT01136642) | National Institute on Drug Abuse (NIDA) | 2010-01-21 |
| Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma (NCT01064921) | Ohio State University Comprehensive Cancer Center | 2010-01-19 |